135 related articles for article (PubMed ID: 24178722)
1. Utilization of some non coded amino acids as isosters of peptide building blocks.
Hlaváček J; Marcová R; Ježek R; Slaninová J
Amino Acids; 1996 Sep; 11(3-4):367-77. PubMed ID: 24178722
[TBL] [Abstract][Full Text] [Related]
2. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
[TBL] [Abstract][Full Text] [Related]
3. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
Meyer JP; Davis P; Lee KB; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1995 Sep; 38(18):3462-8. PubMed ID: 7658433
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
5. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
6. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
7. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
Nakagawa SH; Johansen NL; Madsen K; Schwartz TW; Tager HS
Int J Pept Protein Res; 1993 Dec; 42(6):578-84. PubMed ID: 8307689
[TBL] [Abstract][Full Text] [Related]
8. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
9. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
Salvadori S; Guerrini R; Borea PA; Tomatis R
Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
[TBL] [Abstract][Full Text] [Related]
11. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
[TBL] [Abstract][Full Text] [Related]
12. Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H-Tyr-Tic psi [CH2-NH]Phe-OH) incorporating a reduced peptide bond: an NMR investigation.
Carpenter KA; Wilkes BC; Schiller PW
Biopolymers; 1995 Dec; 36(6):735-49. PubMed ID: 8555421
[TBL] [Abstract][Full Text] [Related]
13. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
Lu YA; Felix AM
Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
[TBL] [Abstract][Full Text] [Related]
14. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
15. N
Schütznerová E; Přibylka A; Krchňák V
Org Biomol Chem; 2018 Jul; 16(29):5359-5362. PubMed ID: 30014064
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and opioid activities of [D-Leu-8]Dynorphin(1-8) analogs containing a reduced peptide bond, psi(CH2-NH).
Ambo A; Adachi T; Sasaki Y
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1547-50. PubMed ID: 7586080
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
[TBL] [Abstract][Full Text] [Related]
18. [A novel synthetic approach of tryptophan-containing cystine peptides by regioselective disulfide bond-forming reaction using the silyl chloride-sulfoxide system].
Fujiwara Y
Yakugaku Zasshi; 2000 Feb; 120(2):197-205. PubMed ID: 10689966
[TBL] [Abstract][Full Text] [Related]
19. Preparation, isolation, and characterization of Nalpha-Fmoc-peptide isocyanates: solution synthesis of oligo-alpha-peptidyl ureas.
Sureshbabu VV; Patil BS; Venkataramanarao R
J Org Chem; 2006 Sep; 71(20):7697-705. PubMed ID: 16995676
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of linear and cyclic enkephalin analogues containing a psi (E,CH = CH) or psi (CH2CH2) isosteric replacement.
Tourwé D; Couder J; Ceusters M; Meert D; Burks TF; Kramer TH; Davis P; Knapp R; Yamamura HI; Leysen JE
Int J Pept Protein Res; 1992 Feb; 39(2):131-6. PubMed ID: 1325415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
